The induced lipoxygenase in atherosclerotic aorta converts linoleic acid to the platelet chemorepellant factor 13-HODE

Thrombosis Research
T C SimonJ M Bailey

Abstract

Mammalian tissues contain 5-, 12- and 15-lipoxygenases. Only the 15-lipoxygenase can act on linoleic acid, the predominant essential fatty acid of tissues and plasma, producing 13-hydroxyoctadecadienoic acid (13-HODE). Intracellular production of 13-HODE renders endothelial cells resistant to platelet adhesion, while its hydroperoxy precursor, 13-HPODE, synergises with the platelet anti-aggregatory factor prostacyclin. We have found that a 15-lipoxygenase activity is induced in aortas of cholesterol-fed and Watanabe Heritable Hyperlipidemic (WHHL) rabbits. Aortic tissue from WHHL rabbits incubated with 3H-linoleic acid produced a major metabolite identified as 13-HODE, which was formed with an efficiency comparable to the synthesis 15-HETE from arachidonic acid. These findings indicate that the increased aortic 15-lipoxygenase in vascular tissue is capable of producing 13-HODE in vivo. Since platelet adhesion is increased in atherogenesis, and thrombogenesis is a major complication of advanced atherosclerosis, it is suggested that induction of this enzyme may be a protective response to hypercholesterolemia.

References

May 31, 1986·British Medical Journal·R A RiemersmaF Gey
Jul 31, 1987·Biochemical and Biophysical Research Communications·B N SettyM J Stuart
Oct 29, 1987·Biochemical and Biophysical Research Communications·B N Yamaja SettyM J Stuart
Feb 20, 1986·The New England Journal of Medicine·R Ross
Jan 1, 1986·Reviews of Physiology, Biochemistry and Pharmacology·T Simmet, B A Peskar
Sep 15, 1987·Biochemical and Biophysical Research Communications·U F SchadeR Engel
Apr 25, 1985·Biochimica Et Biophysica Acta·P HenrikssonU Diczfalusy
Apr 15, 1983·Biochemical and Biophysical Research Communications·J LarrueH Bricaud

❮ Previous
Next ❯

Citations

Mar 1, 1993·Medicinal Research Reviews·R L JacksonC E Thomas
Jan 1, 1990·Agents and Actions·M R BuchananE Bastida
Mar 24, 2005·Chemistry and Physics of Lipids·P ManiniM d'Ischia
Nov 16, 2002·Prostaglandins & Other Lipid Mediators·Hartmut KuhnRalf Jürgen Kuban
Aug 18, 2000·Free Radical Biology & Medicine·M K Cathcart, V A Folcik
Jun 1, 1994·The Journal of Experimental Medicine·H KühnS Wohlfeil
Nov 15, 1996·The Journal of Clinical Investigation·J ShenL Chan
Mar 1, 1997·The Journal of Clinical Investigation·H KühnC Gniwotta
Jan 30, 2007·Prostaglandins & Other Lipid Mediators·Timothy Hla, Steven J Feinmark
Dec 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·T C SimonJ M Bailey
Jan 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·F SigariP D Reaven
Nov 5, 2005·Molecular Nutrition & Food Research·Hartmut KühnJutta Belkner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.